The enamel matrix derivative (Emdogain®) enhances human tongue carcinoma cells gelatinase production, migration and metastasis formation

Oral Oncology

Volumn 44, Issue 8, 2008, Pages 733-742

  Laaksonen, Matti ^a   Suojanen, Juho ^a   Nurmenniemi, Sini ^b   Läärä, Esa ^c   Sorsa, Timo ^a   Salo, Tuula ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c Department of Mathematical Sciences   (Finland)

Author keywords

Emdogain; Matrix metalloproteinase; Metastasis; Migration; Tongue carcinoma

Indexed keywords

BIOMATERIAL; GELATINASE; GELATINASE A; GELATINASE B; MATRIX PROTEIN; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENAMEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; WOUND CLOSURE; XENOGRAFT; ZYMOGRAPHY;

AMELOGENIN; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; DENTAL ENAMEL PROTEINS; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 47249143737     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.09.008     Document Type: Article

References (35)

1. Heijl L., Heden G., Svardstrom G., and Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodont 24 9 (1997) 705-714
2. Esposito M., Coulthard P., and Wothington H.V. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev 2 (2003)
3. Sculean A., Schwarz F., Becker J., and Brecx M. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review. Med Princ Pract 16 3 (2007) 167-180
4. Gestrelius S., Andersson C., Lidstrom D., Hammarstrom L., and Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodont 24 9 (1997) 685-692
5. Suzuki S., Nagano T., Yamakoshi Y., Gomi K., Arai T., Fukae M., et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-beta. J Dent Res 84 6 (2005) 510-514
6. Kawase T., Okuda K., Yoshie H., and Burns D.M. Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodont Res 35 5 (2000) 291-300
7. Newman S.A., Coscia S.A., Jotwani R., Iacono V.J., and Cutler C.W. Effects of enamel matrix derivative on Porphyromonas gingivalis. J Periodont 74 8 (2003) 1191-1195
8. Somerman M.J., Archer S.Y., Imm G.R., and Foster R.A. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 67 1 (1988) 66-70
9. Kawase T., Okuda K., Yoshie H., and Burns D.M. Anti-TGF-beta antibody blocks enamel matrix derivative-induced up-regulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodont Res 37 4 (2002) 255-262
10. ® on human periodontal fibroblasts in an in vitro wound-healing model. J Periodont Res 38 3 (2003) 290-295
11. Hoang A.M., Oates T.W., and Cochran D.L. In vitro wound healing responses to enamel matrix derivative. J Periodontol 71 8 (2000) 1270-1277
12. Mirastschijski U., Konrad D., Lundberg E., Lyngstadaas S.P., Jorgensen L.N., and Agren M.S. Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 12 1 (2004) 100-108
13. Reynolds J.J. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Review. Oral Dis 2 1 (1996) 70-76
14. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases. J Natl Cancer Inst 87 17 (1997) 1260-1270
15. Franchi A., Santucci M., Masini E., Sardi I., Paglierani M., and Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95 2 (2002) 1902-1910
16. John A., and Tuszynski G. The role of matrix metalloproteinases in tumour angiogenesis and tumour metastasis. Pat Oncol Res 7 1 (2001) 14-23
17. Uitto V.J., Overall C.M., and McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 2000 31 (2003) 77-104
18. Hong S.D., Hong S.P., Lee J.I., and Lim C.Y. Expression of metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to metastatic potential. Oral Oncol 36 2 (2000) 207-213
19. de Vicente J.C., Fresno M.F., Villalain L., Vega J.A., and Hernandez Vallejo G. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41 3 (2005) 283-293
20. Thomas G.T., Lewis M.P., and Speight P.M. Matrix metalloproteinases and oral cancer. Oral Oncol 35 3 (1999) 227-233
21. Salo T., Liotta L.A., Keski-Oja J., Turpeenniemi-Hujanen T., and Tryggvason K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells- role in metastasis. Int J Cancer 30 5 (1982) 669-673
22. Sutinen M., Kainulainen T., Hurskainen T., Vesterlund E., Alexander J.P., Overall C.M., et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer. 77 12 (1998) 2239-2245
23. Ruokolainen H., Pääkkö P., and Turpeenniemi-Hujanen T. Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 10 9 (2004) 3110-3116
24. Heikkilä P., Suojanen J., Pirilä E., Väänänen A., Koivunen E., Sorsa T., et al. Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides. Int J Cancer 118 9 (2006) 2202-2209
25. Haase H.R., and Bartold P.M. Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. J Periodontol 72 3 (2001) 341-348
26. Mäkelä M., Larjava H., Pirilä E., Maisi P., Salo T., Sorsa T., et al. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 251 1 (1999) 67-78
27. Salo T., Mäkelä M., Kylmäniemi M., Autio-Harmainen H., and Larjava H. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70 2 (1994) 176-182
28. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkilä P., et al. Tumour targeting with a selective gelatinase inhibitor. Nature Biotechnol 17 8 (1999) 768-774
29. R Development Core Team. R: a language and environment for statistical computing (Version 2.5.0). Vienna (Austria): R Foundation for Statistical Computing. ISBN: 3-900051-07-0, ; 2007.
30. Kylmäniemi M., Oikarinen A., Oikarinen K., and Salo T. Effects of Dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal and malignant cells. J Dent Res 75 3 (1996) 919-926
31. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., and Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 99 1 (1993) 18-23
32. Takayama T., Suzuki N., Narukawa M., Goldberg H.A., Otsuka K., and Ito K. Enamel matrix derivative is a potent inhibitor of breast cancer cell attachment to bone. Life Sci 76 11 (2005) 1211-1221
33. Matsumoto K., Horikoshi M., Rikimaru K., and Enomoto S. A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med 18 9 (1989) 498-501
34. Hoang A.M., Klebe R.J., Steffensen B., Ryu O.H., Simmer J.P., and Cochran D.L. Amelogenin is a cell adhesion protein. J Dent Res 81 7 (2002) 497-500
35. Schlueter S.R., Carnes D.L., and Cochran D.L. In vitro effects of enamel matrix derivative on microvascular cells. J Periodont 78 1 (2007) 141-151